Medications within dermatology      

FOI REFERENCE: 24081    FOI DATE: 2^nd May 2024    

How many patients were treated in April 2024 (or latest available month) by the Dermatology department with the following drugs:

Abrocitinib (Cibinqo)                           0

Baricitinib (Olumiant)                          0

Dupilumab (Dupixent)                        4

Lebrikizumab (Ebglyss)                      0

Tralokinumab (Adtralza)                     0

Upadacitinib (Rinvoq)                         0